Recommendations for Generating, Evaluating, and Implementing Drug-Drug Interaction Evidence-Reference-Cited by-同舟云学术

Recommendations for Generating, Evaluating, and Implementing Drug-Drug Interaction Evidence

Published:2012-03-27 Issue:4 Volume:32 Page:304-313
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Hines Lisa E.¹,Malone Daniel C.²,Murphy John E.²

Affiliation:

1. Center for Health Outcomes and PharmacoEconomic Research; College of Pharmacy; University of Arizona; Tucson; Arizona

2. Department of Pharmacy Practice and Science; College of Pharmacy; University of Arizona; Tucson; Arizona

Publisher

Wiley

Subject

Pharmacology (medical)

Reference55 articles.

1. Critical issues associated with drug-drug interactions: highlights of a multistakeholder conference;Hines;Am J Health Syst Pharm,2011

2. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data;Solberg;Am J Manag Care,2004

3. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States;Qato;JAMA,2008

4. Assessment of potential drug-drug interactions with a prescription claims database;Malone;Am J Health Syst Pharm,2005

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypharmacy in Psychiatry: An In-depth Examination of Drug-drug Interactions and Treatment Challenges;Current Pharmaceutical Design;2024-06

2. An Assessment of Different Decision Support Software from the Perspective of Potential Drug–Drug Interactions in Patients with Chronic Kidney Diseases;Pharmaceuticals;2024-04-28

3. Incidence and risk factors for potential drug-drug interactions in outpatients receiving opioid analgesics;Expert Opinion on Drug Safety;2024-04-23

4. Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in Switzerland;Frontiers in Pharmacology;2024-04-02

5. Categorical Analysis of Database Consistency in Reporting Drug–Drug Interactions for Cardiovascular Diseases;Pharmaceutics;2024-02-28